Medical Packaging Transition Project Data | DuPont™ Tyvek®

DuPont is investing more than $30 million in the Tyvek® Medical Packaging Transition Project (MPTP) to ensure continuity and flexibility of future supply. To assist medical device manufacturers with their risk assessments, we post specific Tyvek® transition project information on this website as it becomes available.

DuPont™ Tyvek® Medical Packaging Transition Project (MPTP)

Executive Overview
Testing Summary
Milestones
Cell Descriptors
FAQs
NEW: Risk Assessment Building Blocks
NEW: Package Test Results Selector Tool


Medical Packaging Transition Project Industry Reports

-
Industry Summary Report (Pre/Post Sterilization)

DuPont™ Tyvek® Transition Material Property Data

Transition Protocol Materials Specification and Miscellaneous Properties Data Sheet (English)
Transition Protocol Materials Specification and Miscellaneous Properties Data Sheet (Metric)
Tyvek 1073B Current vs. Transition Material Comparisons
Tyvek 1059B Current vs. Transition Material Comparisons
Material Sterilization Details
Specification Properties of 1073B
Specification Properties of 1059B
Miscellaneous Properties of 1073B
Miscellaneous Properties of 1059B
Microbial Barrier Properties of 1073B and 1059B
Effects of Sterilization and Accelerated Aging on Microbial Barrier for 1073B (ASTM F2638)
Effects of Sterilization and Accelerated Aging on Microbial Barrier for 1059B (ASTM F2638)
- Effects of Sterilization on Microbial Barrier for 1073B (ASTM F1608)
- Effects of Sterilization on Microbial Barrier for 1059B (ASTM F1608)

DuPont™ Tyvek® Transition Material Additional Testing (Phantom Protocol Testing)

NEW: Seal Strength Comparison Fingerprints
Effects of Steam Sterilization 
Differential Scanning Calorimetry 
Infrared Spectrum "Fingerprinting" via ATR-FTIR
Hydrostatic Head and Surface Energy
- Freeze-Thaw Dimensional Stability Study
Particle Generation Properties
- Static/Dynamic Coefficient of Friction
- Parker Surface Smoothness

Biocompatibility, Food Contact and Pharmacopeia Results

Biocompatibility, Food Contact and Pharmacopeia Testing

U.S. FDA Protocol Package Data
Data will be published as available

NEW: Package Test Results Selector Tool
Transition Protocol Test Matrix Status
Pre and Post-Sterilization Results
1-Year Accelerated Aging Results for 52 Cells

Phantom Protocol Package Data
Data will be published as available

Phantom Protocol Test Matrix Status

Developmental Material Data

Developmental Materials Data Charts as of September 2012
Additional Accelerated Aging Data - Developmental Materials

Regulatory Guidance

In addition to Tyvek® transition project data, guidance obtained from regulatory authorities around the world is posted to help medical device manufacturers stay informed.

- Guidance from U.S. F.D.A. 

- Regulatory Guidance from Japan

Summary of Guidance from China, CFDA-Jinan
Guidance from Health Canada


European Notified Bodies

- Position Statements with Protocol Review

- Position Statements

Resources

MPTP Industry Collaborators
DuPont MPTP Experts
Industry Organizations
Return back to MPTP Home Page